Meridian Bioscience, Inc. (VIVO) Misses Q4 EPS by 1c; Reaffirms
Tweet Send to a Friend
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q4 EPS of $0.22, $0.01 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
